Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
Go back to Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions| ATA, Inc. (NASDAQ: ATAI) | Delayed: 7.35 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.35 | 52 Week High | $7.32 | |||
| Open | $7.35 | 52 Week Low | $3.30 | |||
| Day High | $7.35 | P/E | N/A | |||
| Day Low | $7.35 | EPS | $0.00 | |||
| Volume | 9,420 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1135.05 +19.35 (1.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1115.70 | 52 Week High | $88.16 | |||
| Open | $1142.20 | 52 Week Low | $67.88 | |||
| Day High | $1153.95 | P/E | 262.74 | |||
| Day Low | $1130.50 | EPS | $4.32 | |||
| Volume | 410,278 | |||||
